Ottawa, Jan. 25, 2022 (GLOBE NEWSWIRE) -- The global joint pain injections market size was reached at USD 3.90 billion in 2020. The geriatrics and the elderly are the most commonly affected by joint problems. The ripping of synovial fluid in the joints caused by injury or ageing causes joint discomfort. Hyaluronic acid, which is found in the synovial fluid, lubricates the spaces between the joints. Hyaluronic acid helps to reduce joint inflammation and pain caused by tissue deterioration and injury. During an injury, hyaluronic acid breaks down, causing joint discomfort and inflammation in the ligaments and tendons that surround the joint.
Get the Report Sample Copy@ https://www.precedenceresearch.com/sample/1449
Osteoarthritis, which is caused by a loss of synovial fluid in the joint area, is a very frequent condition among the elderly. One of the joint pain injections contains hyaluronic acid and are injected directly into the joints to assist alleviate inflammation and pain by filling and lubricating the afflicted area. Psoriatic arthritis, bursitis, gout, osteoarthritis, and other types of joint discomfort are commonly treated with joint pain injections.
Report Highlights
Based on the injection type, the hyaluronic acid injections segment dominated the global joint pain injections market in 2020 with highest market share. Hyaluronic acid injections are used to treat osteoarthritis-related knee discomfort. Hyaluronic acid injections are given to individuals who have failed to respond to pain medications and other treatments. Hyaluronic acid acts as a lubricant and stress absorber in the joints, allowing them to function properly.
Report Scope of the Joint Pain Injections Market
| Report Highlights | Details | |
| Market Size in 2020 | USD 3.90 billion | |
| CAGR from 2021 to 2030 | 6.9 | % |
| Fastest Growing Region | Asia Pacific | |
| Base Year | 2021 | |
| By Product |
| |
| Companies Covered | Anika Therapeutics Inc., Ferring B.V., Bioventus, Ferring Pharmaceuticals Inc., Sanofi, SEIKAGAKU Corporation , Zimmer Biomet Holdings Inc., Pfizer Inc., Chugai Pharmaceutical Co. Ltd, Allergen Plc. | |
Regional Snapshot
Asia-Pacific is expected to witness largest CAGR during the forecast period 2021 to 2030. Asia-Pacific dominates the global joint pain injections market due to rising healthcare expenditures and increased investments in the future years.
North America region accounted largest revenue share in 2020. Due to a huge patient pool and rising disease prevalence, an increase in the senior population, increased obesity, and a high adoption of innovative treatments for joint pain reduction in the region, North America region dominated the global joint pain injections market.
Ask here for more customization study@ https://www.precedenceresearch.com/customization/1449
Market Dynamics
Drivers
Increasing demand for hyaluronic acid injections
The injections segment for joint pain injections market is led by hyaluronic acid injection. Because human joints are like gears that are constantly subjected to wear and tear, hyaluronic acid has excellent lubrication and shock-absorbing properties similar to synovial fluid, reducing joint stiffness and tenderness. Because of its anti-inflammatory properties and ability to provide short-term relief in joint sprains experienced by athletes and industrial workers, corticosteroid injections are used as an adjuvant medication in joint pain. Thus, the increasing demand for hyaluronic acid injections is driving the growth of join pain injections market during the forecast period.
Restraints
Shortage of arthritis specialists
The arthritis is observed mainly in the old age people. The use of joint pain injections requires specialists. But due to lack of resources and knowledge, there is shortage of arthritis specialists in various regions. The shortage of arthritis specialists in developing and underdeveloped regions is one of the restricting factors for the growth of market. On the other hand, the high costs of arthritis injections also hinder the growth of the market. As a result, the shortage of arthritis specialists is expected to hinder the growth of joint pain injections market during the forecast period.
Opportunities
Growing geriatric population
The geriatric population is rapidly growing. According to the United Nations, more than 727 million people are 65 or older. Joint pain and other diseases are common among the elderly population. People aged 65 and up are not in good physical shape. They are unable to visit healthcare clinics and hospitals on a regular basis for health checks. As a result, joint pain injections can be used on a large scale by the geriatric population to avoid frequent hospital visits. As a result, during the forecast period, the growing geriatric population creates new lucrative opportunities for the growth of the joint pain injections market.
Challenges
Lack of awareness about the products
The people are not aware about the joint pain injections. The joint pain injections such as hyaluronic acid injections, corticosteroid injections, and platelet-rich plasma injections. The use of these injections requires proper knowledge and training. The utilization of joint pain injections on patients is mainly done by doctors and healthcare experts. For this, the proper and training is provided to professionals. The lack of government initiatives for the promotion of joint pain injections is a restraint factor for the market. As a result, the lack of awareness about the products is a huge challenge for the growth of joint pain injections market during the forecast period.
Browse more related reports@ https://www.precedenceresearch.com/industry/healthcare
Segments Covered in the Report
By Injection Type
- Corticosteroid Injections
- Hyaluronic Acid Injections
- Platelet-rich Plasma Injections
- Placental tissue matrix (PTM) Injections
By Joint Type
- Knee and Ankle
- Hip
- Shoulder and Elbow
- Spinal Joints
- Others
By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
By Product Type
- Pre-filled injections
- Vials
By Geography
- North America
- Europe
- Asia-Pacific
- MEA
- Latin America
- Rest of the World
Click Here to View Full Report Table of Contents
Buy this Premium Research Report@ https://www.precedenceresearch.com/checkout/1449
You can place an order or ask any questions, please feel free to contact at sales@precedenceresearch.com | +1 9197 992 333
About Us
Precedence Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Precedence Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semi-conductors, chemicals, automotive, and aerospace & defense, among different ventures present globally.
For Latest Update Follow Us:
https://www.linkedin.com/company/precedence-research/
https://www.facebook.com/precedenceresearch/
https://twitter.com/Precedence_R
